New insider activity at Hims & Hers Health ( (HIMS) ) has taken place on August 8, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CMO Patrick Harrison Carroll has recently sold 60,000 shares of Hims & Hers Health stock, amounting to a total transaction value of $3,214,800.
Recent Updates on HIMS stock
In the last 24 hours, Hims & Hers Health has experienced notable developments following its Q2 earnings report. The company reported a 73% year-over-year revenue increase, reaching $545 million, and a 31% rise in subscribers, which contributed to a 220% increase in net income. Despite these strong growth metrics, the company faces challenges such as a decline in GLP-1 revenue and negative free cash flow due to increased investments in working capital and supply chain. Analysts have responded with mixed sentiments; Deutsche Bank raised its price target based on the company’s robust growth and strategic expansions, while Bank of America expressed concerns over potential downside risks. The stock’s options sentiment also reflected mixed views, with a slight bearish tilt as shares dropped by 8.75%. Overall, while the company’s forward-looking guidance remains optimistic, highlighting plans for international expansion and new healthcare offerings, the market’s response indicates caution due to financial pressures and valuation concerns.
Spark’s Take on HIMS Stock
According to Spark, TipRanks’ AI Analyst, HIMS is a Outperform.
Hims & Hers Health’s strong financial performance and positive earnings call sentiment are the primary drivers of its stock score. The company’s robust revenue growth, strategic partnerships, and expansion efforts support its growth trajectory. However, the high P/E ratio suggests that the stock may be overvalued, posing a risk if growth expectations are not met. Technical indicators support a bullish trend, adding to the positive outlook.
To see Spark’s full report on HIMS stock, click here.
More about Hims & Hers Health
YTD Price Performance: 102.58%
Average Trading Volume: 43,130,603
Technical Sentiment Signal: Buy
Current Market Cap: $11.56B